Swiss National Bank’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $858K | Sell |
170,200
-4,500
| -3% | -$22.7K | ﹤0.01% | 2196 |
|
|
2025
Q1 | $1.13M | Hold |
174,700
| – | – | ﹤0.01% | 2074 |
|
|
2024
Q4 | $1.28M | Sell |
174,700
-10,500
| -6% | -$77.1K | ﹤0.01% | 2090 |
|
|
2024
Q3 | $1.39M | Hold |
185,200
| – | – | ﹤0.01% | 2063 |
|
|
2024
Q2 | $1.65M | Hold |
185,200
| – | – | ﹤0.01% | 1916 |
|
|
2024
Q1 | $1.88M | Hold |
185,200
| – | – | ﹤0.01% | 1872 |
|
|
2023
Q4 | $1.86M | Sell |
185,200
-6,300
| -3% | -$63.4K | ﹤0.01% | 1885 |
|
|
2023
Q3 | $1.79M | Buy |
191,500
+2,000
| +1% | +$18.7K | ﹤0.01% | 1905 |
|
|
2023
Q2 | $4.65M | Buy |
189,500
+31,400
| +20% | +$770K | ﹤0.01% | 1360 |
|
|
2023
Q1 | $3.68M | Sell |
158,100
-18,100
| -10% | -$421K | ﹤0.01% | 1449 |
|
|
2022
Q4 | $4.46M | Buy |
176,200
+3,600
| +2% | +$91.1K | ﹤0.01% | 1386 |
|
|
2022
Q3 | $3.33M | Buy |
172,600
+2,700
| +2% | +$52.1K | ﹤0.01% | 1530 |
|
|
2022
Q2 | $4.33M | Buy |
169,900
+15,200
| +10% | +$387K | ﹤0.01% | 1406 |
|
|
2022
Q1 | $3.98M | Buy |
154,700
+11,000
| +8% | +$283K | ﹤0.01% | 1588 |
|
|
2021
Q4 | $6.02M | Hold |
143,700
| – | – | ﹤0.01% | 1331 |
|
|
2021
Q3 | $6.25M | Buy |
143,700
+2,800
| +2% | +$122K | ﹤0.01% | 1302 |
|
|
2021
Q2 | $6.66M | Buy |
+140,900
| New | +$6.66M | ﹤0.01% | 1281 |
|